Results 21 to 30 of about 30,032,226 (297)

Occurrence of mcr-1 and mcr-2 colistin resistance genes in porcine Escherichia coli isolates (2010–2020) and genomic characterization of mcr-2-positive E. coli

open access: yesFrontiers in Microbiology, 2022
IntroductionThe global emergence of plasmid-mediated colistin resistance is threatening the efficacy of colistin as one of the last treatment options against multi-drug resistant Gram-negative bacteria.
Christa Ewers   +5 more
doaj   +1 more source

Prevalence of colistin resistance gene mcr-1 in Escherichia coli isolated from chickens in central China, 2014 to 2019

open access: yesJournal of Global Antimicrobial Resistance, 2022
: Objectives: This study investigated the prevalence and characteristics of mcr-1-harbouring Escherichia coli isolated from chickens in central China from 2014 to 2019. Methods: A total of 1132 E.
Wenting Zhang   +10 more
doaj   +1 more source

sj-docx-1-mcr-10.1177_10775587231194681 – Supplemental material for Hospital and Patient Factors Affecting Veterans’ Hospital Choice

open access: yes, 2023
Supplemental material, sj-docx-1-mcr-10.1177_10775587231194681 for Hospital and Patient Factors Affecting Veterans’ Hospital Choice by Jean Yoon, Michael K. Ong, Megan E. Vanneman, Yue Zhang, Matthew P. Dizon and Ciaran S. Phibbs in Medical Care Research
Yue Zhang (30585)   +5 more
core   +1 more source

Molecular detection of colistin resistance genes (mcr-1 to mcr-5) in human vaginal swabs

open access: yesBMC Research Notes, 2018
Objective Colistin resistance has emerged worldwide and has been threatening the efficacy of one of the last-resort antimicrobials used for treatment of multidrug resistant Gram-negative bacteria. While five colistin resistance genes (mcr-1, mcr-2, mcr-3,
Jilei Zhang   +8 more
doaj   +1 more source

Ecology of blaNDM and mcr-1

open access: yesJournal of Laboratory and Precision Medicine, 2017
Antibiotic resistance is one of the most worrying threats to global public health today. Numerous common infections are becoming harder, and even impossible, to treat due to the loss of effectiveness of these molecules against resistant bacteria.
Jose Francisco Delgado-Blas   +2 more
openaire   +1 more source

Epidemiology, genetic dynamics, and transmission of the <i>mcr-1</i> gene in China. [PDF]

open access: yesEmerg Microbes Infect
Colistin is a broad-spectrum antibiotic that kills bacteria through the disruption of the cell membrane, making it effective against various bacterial infections. Since the first global report of mobile colistin-resistant (mcr-1)-positive bacteria, which were discovered and described by Chinese scientists in 2015, monitoring and research on these ...
Wang B   +14 more
europepmc   +4 more sources

sj-docx-1-mcr-10.1177_10775587231197248 – Supplemental material for Association Between Community Social Vulnerability and Preventable Hospitalizations

open access: yes, 2023
Supplemental material, sj-docx-1-mcr-10.1177_10775587231197248 for Association Between Community Social Vulnerability and Preventable Hospitalizations by Rachel Hogg-Graham, Joseph A. Benitez, Mary E.
Mary E. Lacy (3211308)   +8 more
core   +1 more source

In Vitro/Vivo Activity of Potential MCR-1 Inhibitor in Combination With Colistin Againsts mcr-1-Positive Klebsiella pneumonia [PDF]

open access: yesFrontiers in Microbiology, 2018
Carbapenem resistance among strains of the nosocomial pathogen Klebsiella pneumoniae is increasing worldwide, causing serious clinical infections and higher mortality rates. Polymyxins are some of the few "last resort" options for treatment of carbapenem-resistant Enterobacteriaceae, including K.
Yonglin Zhou   +12 more
openaire   +3 more sources

sj-docx-1-mcr-10.1177_10775587211021172 – Supplemental material for Continuous Eligibility for Medicaid Associated With Improved Child Health Outcomes

open access: yes, 2021
Supplemental material, sj-docx-1-mcr-10.1177_10775587211021172 for Continuous Eligibility for Medicaid Associated With Improved Child Health Outcomes by Erin Brantley and Leighton Ku in Medical Care Research and ...
Erin Brantley (11449143)   +1 more
core   +1 more source

sj-docx-1-mcr-10.1177_10775587221098831 – Supplemental material for Designing Equitable Health Care Outreach Programs From Machine Learning Patient Risk Scores

open access: yes, 2022
Supplemental material, sj-docx-1-mcr-10.1177_10775587221098831 for Designing Equitable Health Care Outreach Programs From Machine Learning Patient Risk Scores by Christopher A.
Christopher A. Hane (6919427)   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy